1 study found for:    NCT01262365
Show Display Options
Rank Status Study
1 Active, not recruiting Study of Epratuzumab Versus Placebo in Subjects With Moderate to Severe General Systemic Lupus Erythematosus
Condition: Systemic Lupus Erythematosus
Interventions: Drug: Epratuzumab;   Drug: Placebo

Indicates status has not been verified in more than two years